EDITION:
- EU
- NA
The future of France’s medical cannabis programme has been thrown into doubt this week as the government failed to introduce...
Read more
This Nov 3rd, join us for the third edition of Business of Cannabis: New York at The Williamsburg Hotel. A day...
Read more
This Nov 3rd, join us for the third edition of Business of Cannabis: New York at The Williamsburg Hotel. A...
This Nov 3rd, join us for the third edition of Business of Cannabis: New York at The Williamsburg Hotel. A...
This Nov 3rd, join us for the third edition of Business of Cannabis: New York at The Williamsburg Hotel. A...
This Nov 3rd, join us for the third edition of Business of Cannabis: New York at The Williamsburg Hotel. A day...
Read more
SWITZERLAND’S largest city Zurich has unveiled details of its adult-use recreational trial which is set to begin in Autumn next...
The past few weeks have been interesting ones on the cannabis front. And perhaps these weeks foreshadow things to come...
CBD edibles such as gummies have expanded massively thanks to a variety of flavours and easy accessibility.
We won’t spam you
MGC Pharmaceuticals MGC Pharmaceuticals, which became the first cannabis company to list on the London Stock Exchange (LSE) in...
Read moreThis Nov 3rd, join us for the third edition of Business of Cannabis: New York at The Williamsburg Hotel. A...
This Nov 3rd, join us for the third edition of Business of Cannabis: New York at The Williamsburg Hotel. A...
This Nov 3rd, join us for the third edition of Business of Cannabis: New York at The Williamsburg Hotel. A...
The slow but steady march of pharmaceutical players into the cannabis industry has spurned a new period of technological innovation,...
Read moreSWITZERLAND’S largest city Zurich has unveiled details of its adult-use recreational trial which is set to begin in Autumn next...
The past few weeks have been interesting ones on the cannabis front. And perhaps these weeks foreshadow things to come...
CBD edibles such as gummies have expanded massively thanks to a variety of flavours and easy accessibility.
We won’t spam you
MGC Pharmaceuticals MGC Pharmaceuticals, which became the first cannabis company to list on the London Stock Exchange (LSE) in...
Apollon Formularies Aquis-listed Apollon Formularies has entered into another agreement to sell its ‘global assets’ after announcing that its...
Cantourage This week Cantourage UK, a subsidiary of the German-listed cannabis distribution group, signed a supply agreement which will...
TWITTER has become the first major social media platform to openly allow the advertisement of cannabis brands. Since the new policy...
FRANCE is wholly reliant on imported products to satisfy the demands of its domestic CBD consumers - despite being Europe's...
WITH a flurry of activity on the exchanges in the last month the question on the lips of many is...
The future of France’s medical cannabis programme has been thrown into doubt this week as the government failed to introduce...
Read moreAlternaleaf, the clinic that’s helped hundreds of thousands of Australians access medical cannabis, today is launching in the UK. The...
Read moreMGC Pharmaceuticals MGC Pharmaceuticals, which became the first cannabis company to list on the London Stock Exchange (LSE) in...
Read moreThis week, British pharmaceutical cannabis firm Oxford Cannabinoid Technologies (OCT) announced that the ‘final dose’ in its crucial Phase I...
Read moreBRITISH CANNABIS™ is pleased to announce the strategic acquisition and continued operation of PhytoVista Laboratories (a UKAS accredited testing laboratory...
Read more“The West can teach the East how to get a living, but the East must eventually be asked to show...
Read moreIn the first of a series of articles taking a deep dive into the market, focusing on everything from its...
Read moreFollowing a period of relative regulatory stagnation and mounting financial pressure, the global cannabis industry has seen a flurry of...
Read more We won’t spam you
© 2023 Prohibition Holdings Ltd. All Rights Reserved.
